FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2015284507> ?p ?o ?g. }

• W2015284507 endingPage "569" @default.
• W2015284507 startingPage "559" @default.
• W2015284507 abstract "The aim of the proposed research work was to develop and validate a simple, selective high sensitive and high-throughput assay for the simultaneous estimation of Atorvastatin and Glimepiride in human plasma using liquid chromatography tandem mass spectrometry (LC-MS/MS). Atorvastatin–Glimepiride combines a competitive inhibitor of HMG-CoA reductase and a sulfonylurea anti-diabetic drug. The purpose of this study was to develop single method for Atorvastatin and Glimepiride in plasma by liquid chromatography-tandem mass spectrometry (LC-MS/MS) that would result into a simultaneous estimation of Atorvastatin and Glimepiride avoiding acid –lactone inter conversions right from sample collections to analysis on the LC-MS/MS. Sample collection procedure optimized for Atorvastatin holds good for Glimepiride, hence resulting into a simultaneous estimation of Atorvastatin and Glimepiride. Liquid-liquid extraction and liquid chromatography coupled to positive ion mode tandem mass spectrometry was used to develop the method and was validated according to US FDA guidelines. The calibration curves for two analytes were linear (R2 ≥ 0.9950, n = 4) over the concentration range of 0.2 - 30 ng/mL for Atorvastatin and 1 - 250 ng/mL for Glimepiride. Mean extraction recoveries 80.34 ± 9.43 for Atorvastatin and 88.19 ± 7.13 for Glimepiride. Intra- and inter-run mean percent accuracy was between 85% - 115% and percent imprecision was ≤15%. Stability studies revealed that Atorvastatin and Glimepiride were stable in plasma during bench top (10.5 h at room temperature), in Injector (47.5 h), at the end of three successive freeze and thaw cycles and long term at -65℃ ± 15℃ for 114 days. The method was successfully applied to the study of pharmacokinetics of Atorvastatin and Glimepiride in healthy volunteers. Simultaneous estimation of Atorvastatin and Glimepiride is cost effective, reduces analysis cycle time, enables effective utilization of resources and reduces bleeding burden on human volunteers." @default.
• W2015284507 created "2016-06-24" @default.
• W2015284507 creator A5017473916 @default.
• W2015284507 creator A5057969333 @default.
• W2015284507 creator A5061739761 @default.
• W2015284507 creator A5073481284 @default.
• W2015284507 creator A5089412198 @default.
• W2015284507 date "2012-01-01" @default.
• W2015284507 modified "2023-10-01" @default.
• W2015284507 title "Simultaneous Determination of Atorvastatin and Glimepiride by LC-MS/MS in Human Plasma and Its Application to a Pharmacokinetic Study" @default.
• W2015284507 cites W1510298788 @default.
• W2015284507 cites W1966135199 @default.
• W2015284507 cites W1973748734 @default.
• W2015284507 cites W1985019611 @default.
• W2015284507 cites W1991671417 @default.
• W2015284507 cites W2007952125 @default.
• W2015284507 cites W2015382603 @default.
• W2015284507 cites W2017506281 @default.
• W2015284507 cites W2024644426 @default.
• W2015284507 cites W2034961413 @default.
• W2015284507 cites W2037223524 @default.
• W2015284507 cites W2037558790 @default.
• W2015284507 cites W2042770434 @default.
• W2015284507 cites W2044770108 @default.
• W2015284507 cites W2050130279 @default.
• W2015284507 cites W2052537339 @default.
• W2015284507 cites W2052766619 @default.
• W2015284507 cites W2054802881 @default.
• W2015284507 cites W2069311426 @default.
• W2015284507 cites W2070534885 @default.
• W2015284507 cites W2082761856 @default.
• W2015284507 cites W2083670529 @default.
• W2015284507 cites W2083788788 @default.
• W2015284507 cites W2120561917 @default.
• W2015284507 cites W2120928527 @default.
• W2015284507 cites W2121129723 @default.
• W2015284507 cites W2135270007 @default.
• W2015284507 cites W2146427394 @default.
• W2015284507 cites W2328864493 @default.
• W2015284507 doi "https://doi.org/10.4236/ajac.2012.38074" @default.
• W2015284507 hasPublicationYear "2012" @default.
• W2015284507 type Work @default.
• W2015284507 sameAs 2015284507 @default.
• W2015284507 citedByCount "17" @default.
• W2015284507 countsByYear W20152845072012 @default.
• W2015284507 countsByYear W20152845072013 @default.
• W2015284507 countsByYear W20152845072014 @default.
• W2015284507 countsByYear W20152845072017 @default.
• W2015284507 countsByYear W20152845072018 @default.
• W2015284507 countsByYear W20152845072019 @default.
• W2015284507 countsByYear W20152845072021 @default.
• W2015284507 countsByYear W20152845072022 @default.
• W2015284507 crossrefType "journal-article" @default.
• W2015284507 hasAuthorship W2015284507A5017473916 @default.
• W2015284507 hasAuthorship W2015284507A5057969333 @default.
• W2015284507 hasAuthorship W2015284507A5061739761 @default.
• W2015284507 hasAuthorship W2015284507A5073481284 @default.
• W2015284507 hasAuthorship W2015284507A5089412198 @default.
• W2015284507 hasBestOaLocation W20152845071 @default.
• W2015284507 hasConcept C10390740 @default.
• W2015284507 hasConcept C112705442 @default.
• W2015284507 hasConcept C119128265 @default.
• W2015284507 hasConcept C134018914 @default.
• W2015284507 hasConcept C162356407 @default.
• W2015284507 hasConcept C185592680 @default.
• W2015284507 hasConcept C23531484 @default.
• W2015284507 hasConcept C2776307423 @default.
• W2015284507 hasConcept C2777180221 @default.
• W2015284507 hasConcept C2777482532 @default.
• W2015284507 hasConcept C31827203 @default.
• W2015284507 hasConcept C43617362 @default.
• W2015284507 hasConcept C555293320 @default.
• W2015284507 hasConcept C64489805 @default.
• W2015284507 hasConcept C71043704 @default.
• W2015284507 hasConcept C71924100 @default.
• W2015284507 hasConcept C98274493 @default.
• W2015284507 hasConceptScore W2015284507C10390740 @default.
• W2015284507 hasConceptScore W2015284507C112705442 @default.
• W2015284507 hasConceptScore W2015284507C119128265 @default.
• W2015284507 hasConceptScore W2015284507C134018914 @default.
• W2015284507 hasConceptScore W2015284507C162356407 @default.
• W2015284507 hasConceptScore W2015284507C185592680 @default.
• W2015284507 hasConceptScore W2015284507C23531484 @default.
• W2015284507 hasConceptScore W2015284507C2776307423 @default.
• W2015284507 hasConceptScore W2015284507C2777180221 @default.
• W2015284507 hasConceptScore W2015284507C2777482532 @default.
• W2015284507 hasConceptScore W2015284507C31827203 @default.
• W2015284507 hasConceptScore W2015284507C43617362 @default.
• W2015284507 hasConceptScore W2015284507C555293320 @default.
• W2015284507 hasConceptScore W2015284507C64489805 @default.
• W2015284507 hasConceptScore W2015284507C71043704 @default.
• W2015284507 hasConceptScore W2015284507C71924100 @default.
• W2015284507 hasConceptScore W2015284507C98274493 @default.
• W2015284507 hasIssue "08" @default.
• W2015284507 hasLocation W20152845071 @default.
• W2015284507 hasOpenAccess W2015284507 @default.
• W2015284507 hasPrimaryLocation W20152845071 @default.
• W2015284507 hasRelatedWork W1979998703 @default.

• next